Details for Patent: 9,480,682
✉ Email this page to a colleague
Which drugs does patent 9,480,682 protect, and when does it expire?
Patent 9,480,682 protects GALAFOLD and is included in one NDA.
This patent has forty patent family members in seventeen countries.
Summary for Patent: 9,480,682
Title: | Methods for treatment of Fabry disease |
Abstract: | Provided are in vitro and in vivo methods for determining whether a patient with Fabry disease will respond to treatment with a specific pharmacological chaperone. |
Inventor(s): | Lockhart; David (Del Mar, CA), Castelli; Jeff (New Hope, PA) |
Assignee: | Amicus Therapeutics, Inc. (Cranbury, NJ) |
Application Number: | 14/641,707 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,480,682 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Delivery; Dosage form; |
Drugs Protected by US Patent 9,480,682
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | THE TREATMENT OF FABRY PATIENTS | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,480,682
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2007253900 | ⤷ Try a Trial | |||
Canada | 2652553 | ⤷ Try a Trial | |||
Cyprus | 1115180 | ⤷ Try a Trial | |||
Cyprus | 1117656 | ⤷ Try a Trial | |||
Denmark | 2533050 | ⤷ Try a Trial | |||
Denmark | 2787345 | ⤷ Try a Trial | |||
European Patent Office | 2024745 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |